We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-18.78%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$33.5B
AUM Growth
-$7.23B
(-18%)
Cap. Flow
+$2.49B
Cap. Flow
% of AUM
7.42%
Top 10 Holdings %
Top 10 Hldgs %
22.78%
Holding
819
New
108
Increased
248
Reduced
319
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$526M |
| 2 |
Honeywell
HON
|
+$192M |
| 3 |
RTN
Raytheon Company
RTN
|
+$162M |
| 4 |
Lockheed Martin
LMT
|
+$158M |
| 5 |
WPX
WPX Energy, Inc.
WPX
|
+$138M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$349M |
| 2 |
AT&T
T
|
+$127M |
| 3 |
3M
MMM
|
+$118M |
| 4 |
Johnson Controls International
JCI
|
+$117M |
| 5 |
L3Harris
LHX
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.23% |
| 2 | Technology | 19.12% |
| 3 | Financials | 11.7% |
| 4 | Consumer Discretionary | 10.23% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRVL
551
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $6.05M | 0.02% |
496,169
| – | – |
|
|
BLU
552
DELISTED
BELLUS Health Inc.
BLU
| $5.99M | 0.02% |
600,000
-700,000
| -54% | -$6.24M |
|
553
Lincoln National
LNC
$8.82B
| $5.98M | 0.02% |
227,361
-94,100
| -29% | -$4.47M |
|
|
JBTM
554
JBT Marel
JBTM
$6.33B
| $5.98M | 0.02% |
80,565
-219,435
| -73% | -$22M |
|
555
Beam Therapeutics
BEAM
$2.88B
| $5.98M | 0.02% |
+332,000
| New | +$7.22M |
|
556
Carnival Corporation Ltd
CCL
$39.3B
| $5.96M | 0.02% |
452,300
-8,300
| -2% | -$295K |
|
557
Federal Realty Investment Trust
FRT
$10.2B
| $5.92M | 0.02% |
79,300
-1,500
| -2% | -$173K |
|
558
Aurinia Pharmaceuticals
AUPH
$2.11B
| $5.8M | 0.02% |
+400,000
| New | +$7.06M |
|
559
IDEX
IEX
$17.3B
| $5.72M | 0.02% |
41,426
-43,200
| -51% | -$6.78M |
|
560
Newell Brands
NWL
$2.53B
| $5.7M | 0.02% |
429,300
-7,900
| -2% | -$136K |
|
|
TPTX
561
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $5.58M | 0.02% |
125,000
+100,000
| +400% | +$5.31M |
|
|
EMBJ
562
Embraer S.A. ADS
EMBJ
$13B
| $5.5M | 0.02% |
743,117
+665,000
| +851% | +$10.1M |
|
563
Equifax
EFX
$20.9B
| $5.48M | 0.02% |
45,900
+8,800
| +24% | +$1.28M |
|
564
Kura Oncology
KURA
$842M
| $5.47M | 0.02% |
550,000
+500,000
| +1,000% | +$5.72M |
|
565
Zions Bancorporation
ZION
$10.3B
| $5.38M | 0.02% |
200,986
+11,500
| +6% | +$474K |
|
566
Perrigo
PRGO
$1.75B
| $5.33M | 0.02% |
110,796
-3,380
| -3% | -$181K |
|
|
NLSN
567
DELISTED
Nielsen Holdings plc
NLSN
| $5.08M | 0.02% |
404,994
-7,400
| -2% | -$139K |
|
|
CLLS
568
Cellectis
CLLS
$275M
| $5.06M | 0.02% |
550,000
-25,000
| -4% | -$373K |
|
569
Packaging Corp of America
PKG
$22.6B
| $5.02M | 0.02% |
57,800
-48,800
| -46% | -$4.73M |
|
570
Outfront Media
OUT
$5.49B
| $5.01M | 0.02% |
+377,924
| New | +$9.24M |
|
571
Axsome Therapeutics
AXSM
$10.9B
| $5M | 0.01% |
+85,000
| New | +$6.93M |
|
572
Lamar Advertising Co
LAMR
$16B
| $4.95M | 0.01% |
+96,567
| New | +$7.78M |
|
573
American Airlines Group
AAL
$10.6B
| $4.86M | 0.01% |
398,357
-91,525
| -19% | -$2.09M |
|
574
Robert Half
RHI
$4.23B
| $4.86M | 0.01% |
128,600
-2,400
| -2% | -$130K |
|
575
Dynatrace
DT
$14.4B
| $4.77M | 0.01% |
200,000
+150,000
| +300% | +$4.32M |
|
Similar funds
Adage Capital Partners's Q1 2020 Portfolio in Review
As of Q1 2020, Adage Capital Partners held 819 positions worth $33.5B, down 18% from $40.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Adage Capital Partners deployed $2.49B of net new capital in Q1 2020, opening 108 new positions and adding to 248 existing holdings. Its largest new stake was Raytheon Company: 818,400 shares worth $107M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was RTX Corp, an estimated $349M trimmed.
- Adage Capital Partners's largest Q1 2020 buy was Raytheon Company: 818,400 shares worth $107M.
- Adage Capital Partners added most to Allergan plc in Q1 2020, an estimated $526M increase.
- Adage Capital Partners's biggest Q1 2020 reduction was RTX Corp, cutting an estimated $349M.
- Adage Capital Partners fully exited 3M in Q1 2020, selling an estimated $118M.
- Adage Capital Partners's ten largest holdings make up 23% of its $33.5B portfolio in Q1 2020.
- Adage Capital Partners opened 108 new positions and closed 97 in Q1 2020.
- Adage Capital Partners's portfolio value fell 18% quarter-over-quarter to $33.5B.
Based on Adage Capital Partners's 13F filing for Q1 2020, filed 15 May 2020.